急性内科病房出院的老年房颤患者直接口服抗凝药处方适宜性
研究纳入意大利39个老年与肾内科病房的609例≥65岁房颤患者(平均85岁),评估出院时DOAC处方适宜性。出院时33%用DOAC、26%用维生素K拮抗剂、41%未抗凝;DOAC者中31%违反smPC(主要为剂量不足17%)、48%属Beers/STOPP不适宜、18%存在药物相互作用。高龄、低BMI、癌症和高eGFR与剂量不足或漏处方独立相关,提示老年住院患者DOAC处方欠佳。
要点
- 老年房颤患者出院时41%未接受任何抗凝,DOAC剂量不足占17%。
- DOAC使用者中48%存在Beers/STOPP不适宜处方,18%有药物相互作用。
- 高龄、低BMI、癌症和高eGFR与DOAC剂量不足或漏处方独立相关。
核心结论
- 老年急性内科病房出院的房颤患者DOAC处方实践欠佳,漏处方和剂量不足常见。
- 医生对真实世界中高龄衰弱患者的出血风险过度担忧,与现行推荐不符。
研究设计与样本
- 研究为队列分析,纳入意大利39个老年与肾内科病房的609例房颤患者,年龄≥65岁,平均85岁。
- 根据smPC、2019 Beers和STOPP标准及药物相互作用评估DOAC处方适宜性。
主要发现
- 出院时33%房颤患者处方DOAC,26%处方维生素K拮抗剂,41%未接受任何抗凝。
- DOAC治疗者中31%违反smPC标准,主要为剂量不足(17%),48%存在Beers/STOPP不适宜处方,18%存在药物相互作用。
- 高龄与剂量不足独立相关(aOR 1.06,95%CI 1.00-1.12),高eGFR与剂量不足独立相关(aOR 1.04,95%CI 1.02-1.07)。
- 低BMI与漏处方独立相关(aOR 0.95,95%CI 0.91-0.99),癌症与漏处方独立相关(aOR 1.93,95%CI 1.19-3.13)。
关键数值与推荐
- DOAC处方适宜性依据smPC、2019 Beers和STOPP标准及药物相互作用进行评价。
临床怎么用
- 临床药师应关注老年房颤患者出院时的抗凝处方,核查DOAC剂量是否按smPC调整。
- 对高龄、低BMI、癌症或高eGFR患者,应警惕DOAC剂量不足或漏处方,并评估药物相互作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Knowledge on the prescriptive practice of direct oral anticoagulants (DOACs) in older subjects with atrial fibrillation (AF) hospitalized in acute medical wards is limited. This study aimed to evaluate the prevalence and appropriateness of DOAC prescriptions in hospitalized older subjects with AF, discharged from acute medical wards. METHODS: We analysed a cohort of 609 subjects with AF, aged ≥65 years (mean age 85 years) enrolled from 39 geriatric and nephrology wards in Italy. DOAC prescriptive appropriateness was evaluated according to the summary of product characteristics (smPC), 2019 Beers and STOPP criteria, and drug-drug interactions (DDIs). RESULTS: At hospital discharge, 33% of patients with AF were prescribed with DOAC, 26% with vitamin-K antagonist, while 41% did not receive any anticoagulant. Among subjects on DOAC therapy, 31% presented a violation of the smPC criteria (mainly underdosage-17%), while 48% and 18% presented a Beers/STOPP inappropriate prescription, or a DDI, respectively. Older age, lower body mass index (BMI), cancer and higher estimated glomerular filtration rate (eGFR) were independently associated with DOAC underdosage or missed prescription (age: adjusted odds ratio [aOR] 1.06, 95% confidence interval [95% CI] 1.00-1.12 for underdosage; eGFR: aOR 1.04, 95% CI 1.02-1.07 for underdosage; BMI: aOR 0.95, 95% CI 0.91-0.99 for missed prescription; cancer: aOR 1.93, 95% CI 1.19-3.13 for missed prescription). CONCLUSIONS: This study showed a suboptimal DOAC prescriptive practice in older in-patients, with frequent missed prescription and DOAC underdosage. Contrary to current recommendations, physicians appear overly concerned by bleeding risk in real-life older and frailer subjects. Strategies should be developed to promote appropriate DOAC prescription in the hospital setting.
引用
- De Vincentis A, Soraci L, Arena E, et al. Appropriateness of direct oral anticoagulant prescribing in older subjects with atrial fibrillation discharged from acute medical wards. Br J Clin Pharmacol. 2024. PMID: 38321367. doi:10.1111/bcp.16010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。